233 related articles for article (PubMed ID: 30026877)
1. Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching.
Ma S; Motevalli SM; Chen J; Xu MQ; Wang Y; Feng J; Qiu Y; Han D; Fan M; Ding M; Fan L; Guo W; Liang XJ; Cao F
Theranostics; 2018; 8(13):3693-3706. PubMed ID: 30026877
[TBL] [Abstract][Full Text] [Related]
2. Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice.
Wang Q; Wang Y; Liu S; Sha X; Song X; Dai Y; Zhao M; Cai L; Xu K; Li J
J Nanobiotechnology; 2021 Jul; 19(1):222. PubMed ID: 34320994
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques.
Xu M; Mao C; Chen H; Liu L; Wang Y; Hussain A; Li S; Zhang X; Tuguntaev RG; Liang XJ; Guo W; Cao F
Acta Pharm Sin B; 2022 Apr; 12(4):2014-2028. PubMed ID: 35847489
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
[TBL] [Abstract][Full Text] [Related]
5. Protein deglycase DJ-1 deficiency induces phenotypic switching in vascular smooth muscle cells and exacerbates atherosclerotic plaque instability.
Wang ZY; Cheng J; Liu B; Xie F; Li CL; Qiao W; Lu QH; Wang Y; Zhang MX
J Cell Mol Med; 2021 Mar; 25(6):2816-2827. PubMed ID: 33501750
[TBL] [Abstract][Full Text] [Related]
6. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.
Ding Y; Zhang M; Zhang W; Lu Q; Cai Z; Song P; Okon IS; Xiao L; Zou MH
Circ Res; 2016 Sep; 119(6):718-30. PubMed ID: 27439892
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.
Liu Z; Zhang M; Zhou T; Shen Q; Qin X
Atherosclerosis; 2018 Sep; 276():58-66. PubMed ID: 30036742
[TBL] [Abstract][Full Text] [Related]
8. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis.
Kim J; Jang SW; Park E; Oh M; Park S; Ko J
J Mol Cell Cardiol; 2014 Jul; 72():157-67. PubMed ID: 24650873
[TBL] [Abstract][Full Text] [Related]
9. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
Chen J; Cao Z; Guan J
BMC Cardiovasc Disord; 2018 Apr; 18(1):72. PubMed ID: 29703160
[TBL] [Abstract][Full Text] [Related]
10. p-Cresyl sulfate promotes the formation of atherosclerotic lesions and induces plaque instability by targeting vascular smooth muscle cells.
Han H; Chen Y; Zhu Z; Su X; Ni J; Du R; Zhang R; Jin W
Front Med; 2016 Sep; 10(3):320-9. PubMed ID: 27527366
[TBL] [Abstract][Full Text] [Related]
11. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.
Chen W; Yu F; Di M; Li M; Chen Y; Zhang Y; Liu X; Huang X; Zhang M
Atherosclerosis; 2018 Oct; 277():98-107. PubMed ID: 30193190
[TBL] [Abstract][Full Text] [Related]
13. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
[TBL] [Abstract][Full Text] [Related]
14. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
[TBL] [Abstract][Full Text] [Related]
15. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
16. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
17. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290
[TBL] [Abstract][Full Text] [Related]
18. Autophagy: a killer or guardian of vascular smooth muscle cells.
Zhang YY; Shi YN; Zhu N; Wang W; Deng CF; Xie XJ; Liao DF; Qin L
J Drug Target; 2020 Jun; 28(5):449-455. PubMed ID: 31835918
[TBL] [Abstract][Full Text] [Related]
19. [Impact of CD137-CD137L signaling mediated exocytosis of autophagosome within vascular smooth muscle cells on the formation of atherosclerotic calcification].
Li B; Li XY; Zhong W; Shao C; Wang ZQ; Yuan W; Yan JC
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):49-56. PubMed ID: 28100346
[No Abstract] [Full Text] [Related]
20. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
